In Vitro Diagnostics Market by Product & Service (Reagents, Instruments, and Software & Services), Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Others), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Others), and End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL3935210
- 381 Pages
- June 2020
- Medical Devices
In vitro diagnostics (IVD) are defined as medical devices and reagents which are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from human body to detect diseases, conditions, and infections. The tests can be performed in stand-alone laboratory, hospital-based laboratory, and point-of-care centers. Some significant technologies incorporated in in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Moreover, other techniques that are used to perform in vitro diagnosis involve clinical chemistry, tissue diagnostics, immunodiagnostics, hematology, and others. For instance, in clinical chemistry various tests are performed in laboratory such as liver panel test, lipid profile, thyroid function test, and others.
Furthermore, a thyroid function test is performed by collecting blood from a patient, which is then tested to check the level of thyroid stimulating hormone (TSH) in blood. Similarly, others such as polymerase chain reaction (PCR) are used to detect the presence of infectious diseases such as HIV, hepatitis, and others. In addition, constant innovations related to IVD products, service designs, and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others.
The major factor that contributes to the growth of the in vitro diagnostic market include surge in number of in vitro diagnostic tests, which is attributable to rise in incidences of chronic and infectious diseases. Furthermore, growth in geriatric population, which is prone to immunological disorders is another major factor that boosts the growth of the market. Moreover, rise in use of personalized medicines in treatment of various chronic diseases such as cancer also fuels the growth of the market. In addition, increase in technological advancements associated with in vitro diagnostic products, technologies, and software & services boosts the market growth. However, stringent government regulations and unfavorable reimbursement policies are anticipated to restrict the growth of the in vitro diagnostics market. On the contrary, high growth rate exhibited by developing economies present lucrative opportunities for key players in the in vitro diagnostics market during the forecast period.
The report segments the market across into product & service, technique, application, end user, and region. On the basis of product & service, the market is segmented into reagents, instruments, and services & software. On the basis of technique, it is categorized into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. In addition, the immunodiagnostics segment is further divided into types such as enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. Moreover, the ELSIA segment is further divided into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Similarly, the molecular diagnostics segment is divided into polymerize chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarray, and others.
The clinical chemistry segment is also further divided basic metabolic panel, liver panel, lipid profile, thyroid function panel, electrolyte panel, specialty chemicals, and others.
On the basis of application, the market segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. On the basis of end user, it is categorized into standalone laboratories, hospitals, academics & medical schools, point-of-care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players in the in vitro diagnostics market are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.
KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global negative pressure wound therapy devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
• By Product & Service
o Reagents
o Instruments
o Software and Services
• By Technique
o Immunodiagnostics
§ Enzyme-Linked Immunosorbent Assay (ELISA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence immunoassay (FIA)
• Colorimetric Immunoassay (CI)
§ Rapid Tests
§ Enzyme-Linked ImmunoSpot (ELISPOT)
§ Radioimmunoassay (RIA)
§ Western Blot
o Hematology
o Molecular Diagnostics
§ Polymerize Chain Reaction (PCR)
§ Isothermal Nucleic Acid Amplification Technology (INAAT)
§ Hybridization
§ DNA diagnostics
§ Microarray
§ Others
o Tissue Diagnostics
o Clinical Chemistry
§ Basic Metabolic Panel
§ Liver Panel
§ Lipid Profile
§ Thyroid Function Panel
§ Electrolyte Panel
§ Specialty Chemicals
o Others
• By Application
o Infectious Diseases
o Cancer
o Cardiac Diseases
o Immune System Disorders
o Nephrological Diseases
o Gastrointestinal Diseases
o Others
• By End User
o Standalone Laboratories
o Hospitals
o Academic & Medical Schools
o Point-of-Care
o Others
• By Region
o North America
§ U.S.
§ Canada
§ Mexico
o Europe
§ Germany
§ France
§ UK
§ Italy
§ Spain
§ Rest of Europe
o Asia-Pacific
§ Japan
§ China
§ India
§ Australia
§ South Korea
§ Rest of Asia-Pacific
o LAMEA
§ Brazil
§ Saudi Arabia
§ South Africa
§ Rest of LAMEA
• List of key players profiled in the report:
• Abbott Laboratories
• Becton, Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Beckman Coulter, Inc.)
• F. Hoffmann-La Roche AG
• Siemens AG
• QIAGEN N.V.
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• DiaSorin
• Johnson & Johnson
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Top winning strategies, 2019
3.4.Top player positioning, 2019
3.5.Porters five forces analysis
3.6.Market dynamics
3.6.1.Drivers
3.6.1.1.Increase in incidences of chronic and infectious diseases
3.6.1.2.Technological advancements in IVD
3.6.1.3.Rise in adoption of in vitro diagnostic testing
3.6.1.4.Increase in government expenditures on healthcare
3.6.1.5.Increase in popularity of personalized medicine approach
3.6.2.Restraint
3.6.2.1.Unclear reimbursement policies
3.6.2.2.Stringent regulatory policies
3.6.3.Opportunities
3.6.3.1.Potential opportunities for outsourcing
3.6.3.2.Convergence of new technologies
3.6.4.Impact Analysis
3.7.COVID-19 Impact Analysis for In Vitro Diagnostics Market
CHAPTER 4:IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
4.1.Overview
4.1.1.Market size and forecast
4.2.Reagents
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Instruments
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Software & Services
4.4.1.Market size and forecast, by region
4.4.2.Market analysis, by country
CHAPTER 5:IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE
5.1.Overview
5.1.1.Market size and forecast
5.2.Immunodiagnostics
5.2.1.Market size and forecast, by type
5.2.1.1.Enzyme-linked immunosorbent assay (ELISA)
5.2.1.1.1.Market size and forecast, by type
5.2.1.1.2.Chemiluminescence Immunoassay (CLIA)
5.2.1.1.2.1.Market size and forecast
5.2.1.1.3.Fluoresence immunoassay (FIA)
5.2.1.1.3.1.Market size and forecast
5.2.1.1.4.Colorimetric Immunoassay (CI)
5.2.1.1.4.1.Market size and forecast
5.2.1.2.Rapid Tests
5.2.1.2.1.Market size and forecast
5.2.1.3.Enzyme-linked immunospot (ELISPOT)
5.2.1.3.1.Market size and forecast
5.2.1.4.Radioimmunoassay (RIA)
5.2.1.4.1.Market size and forecast
5.2.1.5.Western blot
5.2.1.5.1.Market size and forecast
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Hematology
5.3.1.Market size and forecast, by region
5.3.2.Market share analysis, by country
5.4.Molecular diagnostics
5.4.1.Market size and forecast, by type
5.4.1.1.Polymerize chain reaction (PCR)
5.4.1.1.1.Market size and forecast
5.4.1.2.Isothermal Nucleic acid amplification technology (INAAT)
5.4.1.2.1.Market size and forecast
5.4.1.3.Hybridization
5.4.1.3.1.Market size and forecast
5.4.1.4.DNA diagnostics
5.4.1.4.1.Market size and forecast
5.4.1.5.Microarray
5.4.1.5.1.Market size and forecast
5.4.1.6.Others
5.4.1.6.1.Market size and forecast
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
5.5.Tissue diagnostics
5.5.1.Market size and forecast, by region
5.5.2.Market share analysis, by country
5.6.Clinical chemistry
5.6.1.Market size and forecast, by type
5.6.1.1.Basic metabolic panel
5.6.1.1.1.Market size and forecast
5.6.1.2.Liver panel
5.6.1.2.1.Market size and forecast
5.6.1.3.Renal profile
5.6.1.3.1.Market size and forecast
5.6.1.4.Lipid profile
5.6.1.4.1.Market size and forecast
5.6.1.5.Thyroid function panel
5.6.1.5.1.Market size and forecast
5.6.1.6.Electrolyte panel
5.6.1.6.1.Market size and forecast
5.6.1.7.Specialty chemicals
5.6.1.7.1.Market size and forecast
5.6.2.Market size and forecast, by region
5.6.3.Market share analysis, by country
5.7.Others
5.7.1.Market size and forecast, by region
5.7.2.Market share analysis, by country
CHAPTER 6:IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Infectious Diseases
6.2.1.Market size and forecast, by region
6.2.2.Market share analysis, by country
6.3.Cancer
6.3.1.Market size and forecast, by region
6.3.2.Market share analysis, by country
6.4.Cardiac diseases
6.4.1.Market size and forecast, by region
6.4.2.Market share analysis, by country
6.5.Immune system disorders
6.5.1.Market size and forecast, by region
6.5.2.Market share analysis, by country
6.6.Nephrological diseases
6.6.1.Market size and forecast, by region
6.6.2.Market share analysis, by country
6.7.Gastrointestinal diseases
6.7.1.Market size and forecast, by region
6.7.2.Market share analysis, by country
6.8.Others
6.8.1.Market size and forecast, by region
6.8.2.Market share analysis, by country
CHAPTER 7:IN VITRO DIAGNOSTICS MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Standalone Laboratories
7.2.1.Market size and forecast, by region
7.2.2.Market share analysis, by country
7.3.Hospitals
7.3.1.Market size and forecast, by region
7.3.2.Market share analysis, by country
7.4.Academic and medical schools
7.4.1.Market size and forecast, by region
7.4.2.Market share analysis, by country
7.5.Point-of-care testing
7.5.1.Market size and forecast, by region
7.5.2.Market share analysis, by country
7.6.Others
7.6.1.Market size and forecast, by region
7.6.2.Market share analysis, by country
CHAPTER 8:IN VITRO DIAGNOSTICS MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country
8.2.2.1.U.S.
8.2.2.1.1.U.S. in vitro diagnostics market, by product & service
8.2.2.1.2.U.S. In vitro diagnostics market, by technique
8.2.2.1.3.U.S. In vitro diagnostics market, by application
8.2.2.1.4.U.S. In vitro diagnostics market, by end user
8.2.2.2.Canada
8.2.2.2.1.Canada iIn vitro diagnostics market, by product & service
8.2.2.2.2.Canada In vitro diagnostics market, by technique
8.2.2.2.3.Canada In vitro diagnostics market, by application
8.2.2.2.4.Canada In vitro diagnostics market, by end user
8.2.2.3.Mexico
8.2.2.3.1.Mexico In vitro diagnostics market, by product & service
8.2.2.3.2.Mexico In vitro diagnostics market, by technique
8.2.2.3.3.Mexico In vitro diagnostics market, by application
8.2.2.3.4.Mexico In vitro diagnostics market, by end user
8.2.3.Market size and forecast, by product & service
8.2.4.Market size and forecast, by technique
8.2.5.Market size and forecast, by application
8.2.6.Market size and forecast, by end user
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany
8.3.2.1.1.Germany In vitro diagnostics market, by product & service
8.3.2.1.2.Germany In vitro diagnostics market, by technique
8.3.2.1.3.Germany In vitro diagnostics market, by application
8.3.2.1.4.Germany In vitro diagnostics market, by end user
8.3.2.2.France
8.3.2.2.1.France In vitro diagnostics market, by product & service
8.3.2.2.2.France In vitro diagnostics market, by technique
8.3.2.2.3.France In vitro diagnostics market, by application
8.3.2.2.4.France In vitro diagnostics market, by end user
8.3.2.3.UK
8.3.2.3.1.UK In vitro diagnostics market, by product & service
8.3.2.3.2.UK In vitro diagnostics market, by technique
8.3.2.3.3.UK In vitro diagnostics market, by application
8.3.2.3.4.UK In vitro diagnostics market, by end user
8.3.2.4.Italy
8.3.2.4.1.Italy In vitro diagnostics market, by product & service
8.3.2.4.2.Italy In vitro diagnostics market, by technique
8.3.2.4.3.Italy In vitro diagnostics market, by application
8.3.2.4.4.Italy In vitro diagnostics market, by end user
8.3.2.5.Spain
8.3.2.5.1.Spain In vitro diagnostics market, by product & service
8.3.2.5.2.Spain In vitro diagnostics market, by technique
8.3.2.5.3.Spain In vitro diagnostics market, by application
8.3.2.5.4.Spain In vitro diagnostics market, by end user
8.3.2.6.Rest of Europe
8.3.2.6.1.Rest of Europe In vitro diagnostics market, by product & service
8.3.2.6.2.Rest of Europe In vitro diagnostics market, by technique
8.3.2.6.3.Rest of Europe In vitro diagnostics market, by application
8.3.2.6.4.Rest of Europe In vitro diagnostics market, by end user
8.3.3.Market size and forecast, by product & service
8.3.4.Market size and forecast, by technique
8.3.5.Market size and forecast, by application
8.3.6.Market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.India
8.4.2.1.1.India In vitro diagnostics market, by product & service
8.4.2.1.2.India In vitro diagnostics market, by technique
8.4.2.1.3.India In vitro diagnostics market, by application
8.4.2.1.4.India In vitro diagnostics market, by end user
8.4.2.2.China
8.4.2.2.1.China In vitro diagnostics market, by product & service
8.4.2.2.2.China In vitro diagnostics market, by technique
8.4.2.2.3.China In vitro diagnostics market, by application
8.4.2.2.4.China In vitro diagnostics market, by end user
8.4.2.3.Japan
8.4.2.3.1.Japan In vitro diagnostics market, by product & service
8.4.2.3.2.Japan In vitro diagnostics market, by technique
8.4.2.3.3.Japan In vitro diagnostics market, by application
8.4.2.3.4.Japan In vitro diagnostics market, by end user
8.4.2.4.Australia
8.4.2.4.1.Australia In vitro diagnostics market, by product & service
8.4.2.4.2.Australia In vitro diagnostics market, by technique
8.4.2.4.3.Australia In vitro diagnostics market, by application
8.4.2.4.4.Australia In vitro diagnostics market, by end user
8.4.2.5.South Korea
8.4.2.5.1.South Korea In vitro diagnostics market, by product & service
8.4.2.5.2.South Korea In vitro diagnostics market, by technique
8.4.2.5.3.South Korea In vitro diagnostics market, by application
8.4.2.5.4.South Korea In vitro diagnostics market, by end user
8.4.2.6.Rest of Asia-Pacific
8.4.2.6.1.Rest of Asia-Pacific In vitro diagnostics market, by product & service
8.4.2.6.2.Rest of Asia-Pacific In vitro diagnostics market, by technique
8.4.2.6.3.Rest of Asia-Pacific In vitro diagnostics market, by application
8.4.2.6.4.Rest of Asia-Pacific In vitro diagnostics market, by end user
8.4.3.Market size and forecast, by product & service
8.4.4.Market size and forecast, by technique
8.4.5.Market size and forecast, by application
8.4.6.Market size and forecast, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil
8.5.2.1.1.Brazil In vitro diagnostics market, by product & service
8.5.2.1.2.Brazil In vitro diagnostics market, by technique
8.5.2.1.3.Brazil In vitro diagnostics market, by application
8.5.2.1.4.Brazil In vitro diagnostics market, by end user
8.5.2.2.Saudi Arabia
8.5.2.2.1.Saudi Arabia In vitro diagnostics market, by product & service
8.5.2.2.2.Saudi Arabia In vitro diagnostics market, by technique
8.5.2.2.3.Saudi Arabia In vitro diagnostics market, by application
8.5.2.2.4.Saudi Arabia In vitro diagnostics market, by end user
8.5.2.3.South Africa
8.5.2.3.1.South Africa In vitro diagnostics market, by product & service
8.5.2.3.2.South Africa In vitro diagnostics market, by technique
8.5.2.3.3.South Africa In vitro diagnostics market, by application
8.5.2.3.4.South Africa In vitro diagnostics market, by end user
8.5.2.4.Rest of LAMEA
8.5.2.4.1.Rest of LAMEA In vitro diagnostics market, by product & service
8.5.2.4.2.Rest of LAMEA In vitro diagnostics market, by technique
8.5.2.4.3.Rest of LAMEA In vitro diagnostics market, by application
8.5.2.4.4.Rest of LAMEA In vitro diagnostics market, by end user
8.5.3.Market size and forecast, by product & service
8.5.4.Market size and forecast, by technique
8.5.5.Market size and forecast, by application
8.5.6.Market size and forecast, by end user
CHAPTER 9:COMPANY PROFILES
9.1.ABBOTT LABORATORIES
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product and service portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.BECTON, DICKINSON AND COMPANY
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product and service portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.BIOMÉRIEUX SA
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product and service portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments
9.4.BIO-RAD LABORATORIES, INC.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product and service portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.DANAHER CORPORATION (BECKMAN COULTER, INC.)
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product and service portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments
9.6.F. HOFFMANN-LA ROCHE AG.
9.6.1.Company snapshot
9.6.2.Operating business segments
9.6.3.Product and service portfolio
9.6.4.Business performance
9.6.5.Key strategic moves and developments
9.7.QIAGEN N.V.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product and service portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.SIEMENS AG (SIEMENS HEALTHINEERS)
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.SYSMEX CORPORATION
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product and service portfolio
9.9.5.Business performance
9.10.THERMO FISHER SCIENTIFIC, INC.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product and service portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments
TABLE 01.IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 02.IN VITRO DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 03.IN VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 04.IN VITRO DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 05.IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 06.IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.IN VITRO DIAGNOSTICS MARKET FOR ELISA, BY TYPE 2019–2027 ($MILLION)
TABLE 08.IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 09.IN VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 2019–2027 ($MILLION)
TABLE 10.MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 11.IN VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.IN VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 2019–2027 ($MILLION)
TABLE 13.CLINICAL CHEMISTRY MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 14.IN VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2019–2027 ($MILLION)
TABLE 15.IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 16.IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 17.IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION,2019–2027 ($MILLION)
TABLE 18.IN VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 2019–2027 ($MILLION)
TABLE 19.IN VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 20.IN VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2019–2027 ($MILLION)
TABLE 21.IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 22.IN VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2019–2027 ($MILLION)
TABLE 23.IN VITRO DIAGNOSTICS MARKET FOR OTHER, BY REGION, 2019–2027 ($MILLION)
TABLE 24.IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 25.IN VITRO DIAGNOSTICS MARKET FOR STANDALONE LABORATORIES, BY REGION, 2019–2027 ($MILLION)
TABLE 26.IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 27.IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOL, BY REGION, 2019–2027 ($MILLION)
TABLE 28.IN VITRO DIAGNOSTICS MARKET FOR POINT-OF-CARE TESTING, BY REGION, 2019–2027 ($MILLION)
TABLE 29.IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 30.IN VITRO DIAGNOSTICS MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 31.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 32.U.S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 33.U.S. IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 34.U.S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 35.U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 36.CANADA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 37.CANADA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 38.CANADA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 39.CANADA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 40.MEXICO IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 41.MEXICO IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 42.MEXICO IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 43.MEXICO IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 44.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 45.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 46.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 47.NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 48.EUROPE IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 49.GERMANY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 50.GERMANY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 51.GERMANY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 52.GERMANY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 53.FRANCE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 54.FRANCE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 55.FRANCE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 56.FRANCE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 57.UK IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 58.UK IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 59.UK IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 60.UK IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 61.ITALY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 62.ITALY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 63.ITALY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 64.ITALY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 65.SPAIN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 66.SPAIN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 67.SPAIN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 68.SPAIN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 69.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 70.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 71.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 72.REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 73.EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 74.EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 75.EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 76.EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 77.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 78.INDIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 79.INDIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 80.INDIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 81.INDIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 82.CHINA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 83.CHINA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 84.CHINA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 85.CHINA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 86.JAPAN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 87.JAPAN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 88.JAPAN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 89.JAPAN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 90.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 91.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 92.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 93.AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 94.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 95.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 96.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 97.SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 98.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 99.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 100.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 101.REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 102.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 103.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 104.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 105.ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 106.LAMEA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 107.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 108.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 109.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 110.BRAZIL IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 111.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 112.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 113.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 114.SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 115.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 116.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 117.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 118.SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 119.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027
TABLE 120.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027
TABLE 121.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027
TABLE 122.REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027
TABLE 123.LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2027 ($MILLION)
TABLE 124.LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2019–2027 ($MILLION)
TABLE 125.LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 126.LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 127.ABBOTT: COMPANY SNAPSHOT
TABLE 128.ABBOTT: OPERATING SEGMENTS
TABLE 129.ABBOTT: PRODUCT AND SERVICE PORTFOLIO
TABLE 130.BD : COMPANY SNAPSHOT
TABLE 131.BD : OPERATING SEGMENTS
TABLE 132.BD: PRODUCT AND SERVICE PORTFOLIO
TABLE 133.BIOMÉRIEUX: COMPANY SNAPSHOT
TABLE 134.BIOMÉRIEUX: OPERATING SEGMENTS
TABLE 135.BIOMÉRIEUX: PRODUCT AND SERVICE PORTFOLIO
TABLE 136.BIO-RAD: COMPANY SNAPSHOT
TABLE 137.BIO-RAD: OPERATING SEGMENTS
TABLE 138.BIO-RAD: PRODUCT AND SERVICE PORTFOLIO
TABLE 139.DANAHER: COMPANY SNAPSHOT
TABLE 140.DANAHER: OPERATING SEGMENTS
TABLE 141.DANAHER: PRODUCT AND SERVICE PORTFOLIO
TABLE 142.ROCHE: COMPANY SNAPSHOT
TABLE 143.ROCHE: OPERATING SEGMENTS
TABLE 144.ROCHE: PRODUCT AND SERVICE PORTFOLIO
TABLE 145.QIAGEN: COMPANY SNAPSHOT
TABLE 146.QIAGEN: OPERATING SEGMENTS
TABLE 147.QIAGEN: PRODUCT AND SERVICE PORTFOLIO
TABLE 148.SIEMENS: COMPANY SNAPSHOT
TABLE 149.SIEMENS: OPERATING SEGMENTS
TABLE 150.SIEMENS: PRODUCT PORTFOLIO
TABLE 151.SYSMEX: COMPANY SNAPSHOT
TABLE 152.SYSMEX: OPERATING SEGMENTS
TABLE 153.SYSMEX: PRODUCT AND SERVICE PORTFOLIO
TABLE 154.THERMO FISHER: COMPANY SNAPSHOT
TABLE 155.THERMO FISHER: OPERATING SEGMENTS
TABLE 156.THERMO FISHER SCIENTIFIC: PRODUCT AND SERVICE PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
